Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2900 of 3284 entries
View as:

A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06103877 Org: User:
Start: 11/01/23 End: 01/28/26 Due: 01/28/27

A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT06147063 Org: User:
Start: 11/27/23 End: 04/10/25 Due: 04/10/26

A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)

Phase: N/A Priority: Normal
NCT ID: NCT01298310 Org: User:
Start: 02/28/11 End: 05/31/12 Due: 05/31/13

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05211895 Org: User:
Start: 02/18/22 End: 09/12/30 Due: 09/12/31

A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT02869438 Org: User:
Start: 11/09/16 End: 08/01/18 Due: 08/01/19

Study to Evaluate the Interaction Between Aspirin and Nexium

Phase: N/A Priority: Normal
NCT ID: NCT01199328 Org: User:
Start: 09/30/10 End: 11/30/10 Due: 11/30/11

A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

Phase: N/A Priority: Normal
NCT ID: NCT04712396 Org: User:
Start: 02/01/21 End: 03/25/21 Due: 03/25/22

A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04613492 Org: User:
Start: 12/02/20 End: 05/31/24 Due: 05/31/25

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00768105 Org: User:
Start: 09/30/08 End: 03/31/09 Due: 03/31/10

Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04930536 Org: User:
Start: 07/14/21 End: 05/02/23 Due: 05/02/24

Brilinta DaYu Study

Phase: N/A Priority: Normal
NCT ID: NCT01870921 Org: User:
Start: 06/26/13 End: 09/30/15 Due: 09/30/16

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT02149199 Org: User:
Start: 07/07/14 End: 08/02/17 Due: 08/02/18

A Study to Assess Multidomain Endpoints of an ECG Patch

Phase: N/A Priority: Normal
NCT ID: NCT06243029 Org: User:
Start: 01/08/24 End: 05/14/25 Due: 05/14/26

Long-term Safety in Atrial Fibrillation Patients

Phase: N/A Priority: Normal
NCT ID: NCT00645853 Org: User:
Start: 10/31/07 End: 05/31/09 Due: 05/31/10

Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine

Phase: N/A Priority: Normal
NCT ID: NCT00937664 Org: User:
Start: 07/31/09 End: 02/28/11 Due: 02/28/12

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05113251 Org: User:
Start: 10/25/21 End: 04/30/27 Due: 04/30/28

Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00692133 Org: User:
Start: 03/31/08 End: 08/31/08 Due: 08/31/09

Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00687232 Org: User:
Start: 01/31/08 End: 05/31/08 Due: 05/31/09

A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

Phase: N/A Priority: Normal
NCT ID: NCT04808518 Org: User:
Start: 12/10/19 End: 11/27/23 Due: 11/27/24

Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH

Phase: N/A Priority: Normal
NCT ID: NCT00607633 Org: User:
Start: 01/31/07 End: 10/31/07 Due: 10/31/08

Covid-19 Data Analyses in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT06652451 Org: User:
Start: 11/12/24 End: 11/29/24 Due: 11/29/25

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT06661733 Org: User:
Start: 11/18/24 End: 12/23/24 Due: 12/23/25

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Phase: N/A Priority: Normal
NCT ID: NCT00654446 Org: User:
Start: 09/30/02 End: 04/30/04 Due: 04/30/05

Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity

Phase: N/A Priority: Normal
NCT ID: NCT00689208 Org: User:
Start: 05/31/07 End: 11/30/08 Due: 11/30/09

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00234468 Org: User:
Start: 01/31/04 End: 08/31/07 Due: 08/31/08